Simple magnetic cell patterning using streptavidin paramagnetic particles.

Experimental Biology and Medicine
Vincent H B HoNigel K H Slater

Abstract

A simple methodology for cell patterning has been developed that can potentially be used to position different types of mammalian cells with high precision. In this method, cell membrane proteins were first biotinylated and then bound to streptavidin paramagnetic particles. The magnetically labeled cells were then seeded onto culture dishes and patterned using low magnetic fields. Highly defined cell patterns were achieved using HeLa, TE671 cells and human monocytes. HeLa and TE671 cells were also sequentially patterned and successfully co-cultured on the same plate using this technique. Cell viability studies proved that this magnetic labeling method was not toxic to cells. Transmission electron microscopy showed that the magnetically labeled HeLa and TE671 cells internalized some of the paramagnetic particles after two days of culture, while the labeled human monocytes did the same after only one hour. Uptake of these particles did not affect the cell patterning and cell viability. This magnetic labeling process is fast, as it involves affinity-based attachment of paramagnetic particles and does not rely on cellular uptake of magnetic materials. It may be adaptable and scalable for various applications.

References

May 1, 1989·Carcinogenesis·M R StrattonC S Cooper
Apr 26, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·C HughesD Darling
Sep 7, 2001·Biosensors & Bioelectronics·A M AravanisG T Kovacs
Feb 9, 2002·Science·Linda G Griffith, Gail Naughton
Sep 5, 2002·Electrophoresis·Jitendra N Mehrishi, Johann Bauer
Feb 26, 2003·Circulation·Bodo E Strauer, Ran Kornowski
Apr 1, 2004·Human Gene Therapy·Ali S ArbabJoseph A Frank
Jun 15, 2004·Biomaterials·Tao XuThomas Boland
Jul 14, 2004·European Radiology·Stephan MetzHeike E Daldrup-Link
Jul 17, 2004·Annual Review of Biomedical Engineering·Christopher S ChenJoe Tien
Jan 26, 2005·Langmuir : the ACS Journal of Surfaces and Colloids·Tsunehisa KimuraShoogo Ueno
May 4, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sharon L WilliamsNigel K H Slater
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ali KhademhosseiniJoseph P Vacanti
Aug 8, 2006·Current Opinion in Biotechnology·Joel Voldman
Nov 17, 2006·Cells, Tissues, Organs·Héctor PereaErich Wintermantel
Jan 12, 2007·Biotechnology and Bioengineering·Kosuke InoHiroyuki Honda
Feb 6, 2007·Angewandte Chemie·An-Hui LuFerdi Schüth
May 29, 2007·Journal of Biomechanics·Steven HughesAlicia J El Haj
Aug 11, 2007·The Journal of Physiology·Mathias HoehnUwe Himmelreich
Nov 21, 2007·Journal of Bioscience and Bioengineering·Akira ItoMasamichi Kamihira
Dec 11, 2007·Journal of Biomedical Materials Research. Part a·Takuro SasakiAkio Minami
May 6, 2008·Biomaterials·Claire Wilhelm, Florence Gazeau

❮ Previous
Next ❯

Citations

Jan 5, 2010·Biomaterials·Vincent H B HoNigel K H Slater
Dec 20, 2016·ACS Applied Materials & Interfaces·Guoyou HuangFeng Xu
Feb 10, 2012·Chemical Society Reviews·Yue PanBing Xu
Mar 26, 2013·Molecular Pharmaceutics·Michinao HashimotoDaniel S Kohane
Oct 23, 2021·ACS Biomaterials Science & Engineering·Kazuhiko IshiharaKyoko Fukazawa

❮ Previous
Next ❯

Methods Mentioned

BETA
biosensing
transmission electron microscopy

Software Mentioned

Analyse
[UNK]

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.